Activation of the Akt/mTOR pathway is critical for cell survival and proliferation in high-risk MDS, with studies showing that mTOR inhibition leads to a significant increase in apoptosis of isolated CD33+ bone marrow cells of high-risk MDS patients, which is an effect not observed in low-risk MDS [49]. The gene discussed is AKT1; the disease is myelodysplastic syndrome.